Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714
Phase 1
120
about 7.2 years
18–65
1 site in AL
What this study is about
This trial is testing a treatment to measure neuroinflammation using a PET scan. The goal is to see if people with chronic pain and fatigue have higher levels of neuroinflammation than healthy individuals, as measured by the PET scan.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take DPA-714 PET/MRI
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Neuroinflammation will be measured in healthy volunteers and compared to neuroinflammation in individuals with pain and fatigue, as measured with [F-18]DPA-714-PET/MRI.
Neurology, Musculoskeletal